Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Richard Tarrant

Contract Qualified Person

As part of my undergraduate degree in Molecular and Cellular Biology at the University of Kent I undertook an industrial placement at the GlaxoSmithKline (GSK) Biopharmaceutical Centre of Excellence for Drug Discovery (BiopharmCEDD) in Beckenham, working within Analytical Development.  After graduating, I worked for a short period of time at the Medicines and Healthcare products Regulatory Agency (MHRA) as a European Coordinator supporting licencing and variations applications and requests. I then moved onto Lonza Biologics (Slough) where I worked within Purification Development as a study director of virus validation studies before embarking on a PhD in Biochemical Engineering at University College London (UCL).  After completing my PhD, I joined the Clinical BioManufacturing Facility (CBF), first as Quality Control Manager, then as Quality Assurance Manager and since 2018, after completing training and my viva assessment, I have been working as a Qualified Person (QP).  As a QP, I have been involved in the final certification and release of various CBF products, including the first COVID-19 vaccine to enter trials in Europe/UK.